308 related articles for article (PubMed ID: 23493728)
1. The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis.
Jarvis JN; Casazza JP; Stone HH; Meintjes G; Lawn SD; Levitz SM; Harrison TS; Koup RA
J Infect Dis; 2013 Jun; 207(12):1817-28. PubMed ID: 23493728
[TBL] [Abstract][Full Text] [Related]
2. Advancing translational immunology in HIV-associated cryptococcal meningitis.
Williamson PR
J Infect Dis; 2013 Jun; 207(12):1793-5. PubMed ID: 23493727
[No Abstract] [Full Text] [Related]
3. Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy.
Chang CC; Lim A; Omarjee S; Levitz SM; Gosnell BI; Spelman T; Elliott JH; Carr WH; Moosa MY; Ndung'u T; Lewin SR; French MA
J Infect Dis; 2013 Sep; 208(6):898-906. PubMed ID: 23766525
[TBL] [Abstract][Full Text] [Related]
4. CD4
Neal LM; Xing E; Xu J; Kolbe JL; Osterholzer JJ; Segal BM; Williamson PR; Olszewski MA
mBio; 2017 Nov; 8(6):. PubMed ID: 29162707
[No Abstract] [Full Text] [Related]
5. Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis.
Jarvis JN; Meintjes G; Bicanic T; Buffa V; Hogan L; Mo S; Tomlinson G; Kropf P; Noursadeghi M; Harrison TS
PLoS Pathog; 2015 Apr; 11(4):e1004754. PubMed ID: 25853653
[TBL] [Abstract][Full Text] [Related]
6. Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency Virus-associated Cryptococcal Meningitis?
Beardsley J; Hoang NLT; Kibengo FM; Tung NLN; Binh TQ; Hung LQ; Chierakul W; Thwaites GE; Chau NVV; Nguyen TTT; Geskus RB; Day JN
Clin Infect Dis; 2019 Apr; 68(9):1494-1501. PubMed ID: 30169607
[TBL] [Abstract][Full Text] [Related]
7. The CSF Immune Response in HIV-1-Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy.
Scriven JE; Graham LM; Schutz C; Scriba TJ; Wilkinson KA; Wilkinson RJ; Boulware DR; Urban BC; Meintjes G; Lalloo DG
J Acquir Immune Defic Syndr; 2017 Jul; 75(3):299-307. PubMed ID: 28346317
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis.
Siddiqui AA; Brouwer AE; Wuthiekanun V; Jaffar S; Shattock R; Irving D; Sheldon J; Chierakul W; Peacock S; Day N; White NJ; Harrison TS
J Immunol; 2005 Feb; 174(3):1746-50. PubMed ID: 15661940
[TBL] [Abstract][Full Text] [Related]
9. HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts.
Tugume L; Rhein J; Hullsiek KH; Mpoza E; Kiggundu R; Ssebambulidde K; Schutz C; Taseera K; Williams DA; Abassi M; Muzoora C; Musubire AK; Meintjes G; Meya DB; Boulware DR;
J Infect Dis; 2019 Feb; 219(6):877-883. PubMed ID: 30325463
[TBL] [Abstract][Full Text] [Related]
10. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
[TBL] [Abstract][Full Text] [Related]
11. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
12. A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis.
Scriven JE; Graham LM; Schutz C; Scriba TJ; Wilkinson KA; Wilkinson RJ; Boulware DR; Urban BC; Lalloo DG; Meintjes G
J Infect Dis; 2016 Jun; 213(11):1725-34. PubMed ID: 26768248
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.
Alemu AS; Kempker RR; Tenna A; Smitson C; Berhe N; Fekade D; Blumberg HM; Aseffa A
PLoS One; 2013; 8(3):e58377. PubMed ID: 23469276
[TBL] [Abstract][Full Text] [Related]
14. Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitis.
Jarvis JN; Bicanic T; Loyse A; Meintjes G; Hogan L; Roberts CH; Shoham S; Perfect JR; Govender NP; Harrison TS
Clin Infect Dis; 2014 Aug; 59(4):493-500. PubMed ID: 24825871
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis.
Robertson EJ; Najjuka G; Rolfes MA; Akampurira A; Jain N; Anantharanjit J; von Hohenberg M; Tassieri M; Carlsson A; Meya DB; Harrison TS; Fries BC; Boulware DR; Bicanic T
J Infect Dis; 2014 Jan; 209(1):74-82. PubMed ID: 23945372
[TBL] [Abstract][Full Text] [Related]
16. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures.
Bicanic T; Brouwer AE; Meintjes G; Rebe K; Limmathurotsakul D; Chierakul W; Teparrakkul P; Loyse A; White NJ; Wood R; Jaffar S; Harrison T
AIDS; 2009 Mar; 23(6):701-6. PubMed ID: 19279443
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis.
Panackal AA; Wuest SC; Lin YC; Wu T; Zhang N; Kosa P; Komori M; Blake A; Browne SK; Rosen LB; Hagen F; Meis J; Levitz SM; Quezado M; Hammoud D; Bennett JE; Bielekova B; Williamson PR
PLoS Pathog; 2015 May; 11(5):e1004884. PubMed ID: 26020932
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
Marais S; Meintjes G; Lesosky M; Wilkinson KA; Wilkinson RJ
AIDS; 2016 Jan; 30(3):395-404. PubMed ID: 26765934
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis.
Skipper CP; Hullsiek KH; Cresswell FV; Tadeo KK; Okirwoth M; Blackstad M; Hernandez-Alvarado N; Fernández-Alarcón C; Walukaga S; Martyn E; Ellis J; Ssebambulidde K; Tugume L; Nuwagira E; Rhein J; Meya DB; Boulware DR; Schleiss MR;
Int J Infect Dis; 2022 Sep; 122():785-792. PubMed ID: 35843498
[TBL] [Abstract][Full Text] [Related]
20. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
